DNA X Inc
SONM
NASDAQ
Technology
$3.44
USD
+0.06 (+1.78%)
At close: Aug 20, 2026, 4:00 PM EDT
Market Cap $5.05M
Volume 7.5K
Revenue
$27.40M
TTM
-34.0%
YoY
Gross Margin
10%
TTM
-42.5%
YoY
Net Income
$-14.78M
TTM
+51.2%
YoY
Operating Cash Flow
$-17.39M
TTM
+3.0%
YoY
Revenue & Net Income
USD Millions
Margins Trend
Percent of revenue
Income Statement Detail
USD Millions, except per-share and share count figures
Metric | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 |
|---|---|---|---|---|---|
Revenue | 0.0 | 11.2 | 16.2 | 0.0 | 0.0 |
YoY Growth | -100.0% | -2.8% | +7.9% | -100.0% | — |
Cost of Revenue | 0.0 | 10.3 | 14.4 | 0.0 | 0.0 |
Gross Profit | 0.0 | 0.8 | 1.8 | 0.0 | 0.0 |
Selling, General & Administrative | 0.9 | 6.7 | 5.6 | 0.0 | 3.6 |
Other Operating Expenses | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Total Operating Expenses | 0.9 | 7.6 | 5.8 | 0.0 | 3.6 |
Operating Income | -0.9 | -6.7 | -4.0 | 0.0 | -3.6 |
EBITDA | 0.2 | -5.9 | -3.0 | 1.5 | -3.6 |
Other Income / Expense | 0.0 | -0.2 | -0.2 | 0.0 | -0.2 |
Total Other Income / Expense | -0.1 | -0.6 | -0.7 | 0.0 | -0.3 |
Income Before Income Taxes | -1.0 | -7.3 | -4.7 | 0.0 | -3.9 |
Income Taxes | 0.0 | 0.1 | 0.1 | 0.0 | 0.0 |
Net Income | 0.5 | -7.5 | -4.8 | -8.9 | 6.3 |
Consolidated Net Income / Loss | 0.5 | -7.5 | -4.8 | 0.0 | 6.3 |
Net Income Attributable to Common Shareholders | 0.5 | -7.5 | -4.8 | 0.0 | 6.3 |
Basic EPS | $1.41 | -$14.22 | -$4.83 | $0.00 | $5.01 |
Diluted EPS | $1.41 | -$14.22 | -$4.83 | $0.00 | $5.01 |
Basic Shares Outstanding | 0.3M | 0.5M | 1.0M | 1.1M | 1.3M |
Diluted Shares Outstanding | 0.3M | 0.5M | 1.0M | 1.1M | 1.3M |